Evidence map›Paper›PMID 37519687›Full record

ReviewHeliyon2023

Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms.

Md Mominur Rahman, Md Rezaul Islam, Shopnil Akash, Md Emon Hossain, Afroza Alam Tumpa, Galib Muhammad Abrar Ishtiaque, Limon Ahmed, Abdur Rauf, Anees Ahmed Khalil, Waleed Al Abdulmonem and 1 more

RetractedOpen access · goldAbstract readReviewRetracted Publication
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. A ProprietaryAntioxidants (Basel, Switzerland) · 2025
    Article
  6. The Role of Pomegranate (Food science & nutrition · 2025
    Review
  7. Article
  8. Article
  9. Natural Modulators of Key Signaling Pathways in Skin Inflammageing.Clinical, cosmetic and investigational dermatology · 2024
    Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Md Mominur RahmanDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Md Rezaul IslamDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Shopnil AkashDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Md Emon HossainDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Afroza Alam TumpaDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Galib Muhammad Abrar IshtiaqueDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Limon AhmedDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Abdur RaufDepartment of Chemistry, University of Swabi, Anbar, Khyber Pakhtunkhwa, Pakistan.
Anees Ahmed KhalilUniversity Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, 54000, Pakistan.
Waleed Al AbdulmonemDepartment of Pathology, College of Medicine Qassim University, Buraydah, Saudi Arabia.
Jesus Simal-GandaraUniversidade de Vigo, Nutrition and Bromatology Group, Analytical Chemistry and Food Science Department, Faculty of Science, E32004 Ourense, Spain.
Daffodil International University · BDQassim University · SAUniversidade de Vigo · ESUniversity of Lahore · PKUniversity of Swabi · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pomegranate, scientifically known as

Indexed as

AngiogenesisApoptosisCell dedifferentiationMetastasisNeoplasticPomegranate

Identifiers

PMID37519687
PMCPMC10372646
OpenAlexW4383645587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.